Paracetamol for multimodal analgesia.

Area of Science:

• Pain Management and Pharmacology
• Geriatric Medicine

Background:

• Pain and disability present significant societal and therapeutic challenges.
• Comorbidities and polypharmacy complicate pain management, particularly in the elderly.
• Multimodal analgesia, combining therapies targeting different pain pathways, offers improved efficacy and safety.

Purpose of the Study:

• To evaluate the role of paracetamol in enhancing multimodal analgesia.
• To assess paracetamol's interactions with other analgesics in preclinical and clinical settings.
• To highlight paracetamol's utility in non-opioid or opioid-sparing pain management strategies.

Main Methods:

• Review of preclinical studies using rodent models of nociceptive and neuropathic pain.
• Analysis of clinical trials involving young and elderly patients with acute and chronic pain.
• Investigation of paracetamol's additive and synergistic effects with anti-inflammatory, opioid, and anti-neuropathic drugs.

Main Results:

• Preclinical data demonstrate additive and synergistic interactions between paracetamol and various analgesic classes.
• Clinical studies confirm paracetamol's effectiveness in multimodal, opioid-sparing regimens.
• Paracetamol enhances analgesia and potentially reduces adverse events in diverse pain conditions.

Conclusions:

• Paracetamol is a valuable component of multimodal analgesia for acute and chronic pain.
• Its use is particularly relevant for the elderly, a growing population experiencing pain.
• Paracetamol facilitates opioid-sparing strategies, improving safety profiles in pain management.